Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor.
Renfrow JJ, Soike MH, West JL, Ramkissoon SH, Metheny-Barlow L, Mott RT, Kittel CA, D'Agostino RB Jr, Tatter SB, Laxton AW, Frenkel MB, Hawkins GA, Herpai D, Sanders S, Sarkaria JN, Lesser GJ, Debinski W, Strowd RE.
Renfrow JJ, et al. Among authors: tatter sb.
Sci Rep. 2020 Sep 16;10(1):15195. doi: 10.1038/s41598-020-72290-2.
Sci Rep. 2020.
PMID: 32938997
Free PMC article.